Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 How I treat patients with myelodysplastic syndromes.

× No keyword cloud information.

29 in total

1. The small population of PIG-A mutant cells in myelodysplastic syndromes do not arise from multipotent hematopoietic stem cells.

Authors: Jeffrey J Pu; Rong Hu; Galina L Mukhina; Hetty E Carraway; Michael A McDevitt; Robert A Brodsky
Journal: Haematologica Date: 2012-02-07 Impact factor: 9.941

2. Outcome of patients with low-risk myelodysplasia after azacitidine treatment failure.

Authors: Thomas Prébet; Sylvain Thepot; Steven D Gore; François Dreyfus; Pierre Fenaux; Norbert Vey
Journal: Haematologica Date: 2012-09-14 Impact factor: 9.941

3. A 4-lncRNA scoring system for prognostication of adult myelodysplastic syndromes.

Authors: Chi-Yuan Yao; Ching-Hsuan Chen; Huai-Hsuan Huang; Hsin-An Hou; Chien-Chin Lin; Mei-Hsuan Tseng; Chein-Jun Kao; Tzu-Pin Lu; Wen-Chien Chou; Hwei-Fang Tien
Journal: Blood Adv Date: 2017-08-16

4. Impact of the degree of anemia on the outcome of patients with myelodysplastic syndrome and its integration into the WHO classification-based Prognostic Scoring System (WPSS).

Authors: Luca Malcovati; Matteo G Della Porta; Corinna Strupp; Ilaria Ambaglio; Andrea Kuendgen; Kathrin Nachtkamp; Erica Travaglino; Rosangela Invernizzi; Cristiana Pascutto; Mario Lazzarino; Ulrich Germing; Mario Cazzola
Journal: Haematologica Date: 2011-06-09 Impact factor: 9.941

5. Immunotoxin resistance via reversible methylation of the DPH4 promoter is a unique survival strategy.

Authors: Hui Wei; Laiman Xiang; Alan S Wayne; Oleg Chertov; David J FitzGerald; Tapan K Bera; Ira Pastan
Journal: Proc Natl Acad Sci U S A Date: 2012-04-16 Impact factor: 11.205

Review 6. Revisiting the case for genetically engineered mouse models in human myelodysplastic syndrome research.

Authors: Ting Zhou; Marsha C Kinney; Linda M Scott; Sandra S Zinkel; Vivienne I Rebel
Journal: Blood Date: 2015-06-15 Impact factor: 22.113

7. Methylation of the DPH1 promoter causes immunotoxin resistance in acute lymphoblastic leukemia cell line KOPN-8.

Authors: Xiaobo Hu; Hui Wei; Laiman Xiang; Oleg Chertov; Alan S Wayne; Tapan K Bera; Ira Pastan
Journal: Leuk Res Date: 2013-08-13 Impact factor: 3.156

Review 8. New strategies in myelodysplastic syndromes: application of molecular diagnostics to clinical practice.

Authors: Zuzana Tothova; David P Steensma; Benjamin L Ebert
Journal: Clin Cancer Res Date: 2013-01-17 Impact factor: 12.531

9. Azacitidine with or without Entinostat for the treatment of therapy-related myeloid neoplasm: further results of the E1905 North American Leukemia Intergroup study.

Authors: Thomas Prebet; Zhuoxin Sun; Rhett P Ketterling; Amer Zeidan; Peter Greenberg; James Herman; Mark Juckett; Mitchell R Smith; Lisa Malick; Elisabeth Paietta; Magdalena Czader; Maria Figueroa; Janice Gabrilove; Harry P Erba; Martin S Tallman; Mark Litzow; Steven D Gore
Journal: Br J Haematol Date: 2015-11-18 Impact factor: 6.998

10. Oral Ezatiostat HCl (TLK199) and Myelodysplastic syndrome: a case report of sustained hematologic response following an abbreviated exposure.

Authors: Fahd Quddus; Jessica Clima; Helen Seedham; Ghulam Sajjad; Naomi Galili; Azra Raza
Journal: J Hematol Oncol Date: 2010-04-23 Impact factor: 17.388